Stanford scaled AI science agents into a 37,000-agent virtual biotech that autonomously designed a lung cancer drug later replicated by Merck.

Scientists from Gladstone Institutes, UC San Francisco and Stanford University, in collaboration with Biohub, have unveiled a ...

Ian reveals how AI is ehancing drug research, and why the first person to receive tomorrow’s newest medicine might not be ...

Researchers at the University of Eastern Finland and the University of Oulu have produced the first chromosome-level ...

Access the latest Labroots virtual event series showcasing cutting-edge genetics and genomics research. Register for upcoming live events to connect with leading experts or watch on-demand sessions to ...

Ever wondered how scientists help diagnose illnesses, identify infections and unlock the secrets hidden within our DNA? Join the Royal Devon University Healthcare NHS Foundation Trust for an exciting, ...

Just two weeks later, AI biologics company Chai Discovery unveiled a licensing agreement with Pfizer that provides the pharmaceutical giant with early access to Chai-3, the company’s AI model for de ...

Five leading cancer researchers from across genomics, proteomics, cell biology, chemical biology and gene therapy dig into ...

AI is cutting clinical trial timelines by up to 50% while improving patient selection, biomarker identification and ...

Scientists from Gladstone Institutes, UC San Francisco, and Stanford University, in collaboration with Biohub, have unveiled a massive ...

Explore 25 breakthroughs in neuroscience that are redefining our understanding of the brain. Discover neuroplasticity, mirror ...